Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 May 4;23(9):e202200059.
doi: 10.1002/cbic.202200059. Epub 2022 Mar 23.

Challenges of the Omicron (B.1.1.529) Variant and Its Lineages: A Global Perspective

Ranjan K Mohapatra  1 , Venkataramana Kandi  2 , Sarika Verma  3   4 , Kuldeep Dhama  5
Affiliations
Review

Challenges of the Omicron (B.1.1.529) Variant and Its Lineages: A Global Perspective

Ranjan K Mohapatra et al. Chembiochem. .

Abstract

The SARS-CoV-2 virus has shown increased ability to mutate over the past two years, especially in the regions of the spike protein and receptor binding sites. Omicron (B.1.1.529) is the fifth variant of concern (VOC) after the emergence of the Alpha, Beta, Gamma, and Delta VOCs of SARS-CoV-2. This new variant has now circulated in 128 countries and according to the Global Initiative on Sharing All Influenza Data (GISAID), these 128 countries have shared 650,657 Omicron genome sequences as of 26 January, 2022. In this article, we highlight the real challenges of Omicron and its different lineages.

Keywords: BA.1; BA.2; BA.3; Omicron lineages; SARS-CoV-2 VOC.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

References

    1. Mohapatra R. K., Kuppili S., Suvvari T. K., Kandi V., Behera A., Verma S., -E-Zahan K., Biswal S. K., Al-Noor T. H., El-ajaily M. M., Sarangi A. K., Dhama K., Chem. Biol. Drug Des. 2022, 10.1111/cbdd.14035. - DOI - PMC - PubMed
    1. Mohapatra R. K., Sarangi A. K., Kandi V., Azam M., Tiwari R., Dhama K., J. Med. Virol. 2022, 10.1002/jmv.27561. - DOI - PMC - PubMed
    1. Mohapatra R. K., Tiwari R., Sarangi A. K., Sharma S. K., Khandia R., Saikumar G., Dhama K., J. Med. Virol. 2022, 10.1002/jmv.27585. - DOI - PMC - PubMed
    1. GISAID, Tracking of variants, 2021, https://www.gisaid.org/hcov19-variants (accessed on January 26, 2022).
    1. WHO, Enhancing response to Omicron SARS-CoV-2 variant, 21 January 2022, https://www.who.int/publications/m/item/enhancing-readiness-for-omicron-... (Accessed January 26, 2022).

Substances